James Ulrich Bowie
CIK: 0002030843
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
EXOZ
EXOZYMES INC.
Director
Discretionary Trading P&L
Holdings
About Bowie James Ulrich
Bowie James Ulrich (SEC CIK 0002030843) files insider reports with the SEC as Director of EXOZYMES INC. (EXOZ).
Signal8 holds 2 ownership filings by Bowie James Ulrich (1 Form 3, 1 Form 4), filed between Nov 18, 2024 and Oct 19, 2026. Those filings report 1 transaction, the latest on Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Bowie James Ulrich's filings is in MONROVIA, CA.
Recent filings by Bowie James Ulrich
- Oct 1, 2026: Grant or award of EXOZ derivative securities (Form 4, code A).
Other insiders filing for EXOZYMES INC. (EXOZ)
- Perriman Damien Alan, Chief Commercial Officer
- Korman Tyler Paz, Chief Scientific Officer
- Rayo Edgardo Javier, Director
- MARLETT CHRISTOPHER A, Director
- Lalonde James Joseph, Director
- DIGIANDOMENICO ANTHONY, Director